Arrhythmia- Atrial fibrillation and SVT Flashcards
differentials for Regular Narrow COmplex Tachycardia with short and long RP interval
short RP
- AVNRT
- AVRT (orthodromic)
- focal AT with 1st degree AV block
diagnosis?
AVNRT
ECG findings for WPW pattern?
- short OR interval
- Prolonged QRS
- delta wave
Arrhythmias associated with WPW syndrome?
Orthrodromic avrt
antidromic avrt
Atrial fibrillation - irregular wide complex tachycardia
diagnosis?
atrial fibrillation
Typical atrial flutter, ecg findings?
- positive in V1
- negative p wave in inferior wall
***dependent on Cavotricuspid isthmus
Atypical Atrial flutter, ecg findings
positive P waves on both V1 and inferior leads
***clues: more likely in prior cardiac surgery/ablation or radiation
Beta blockers vs CCB. which are more effective for MFAT?
CCB
what are the stages of Atrial Fibrillation?
Stage 1 - At risk for Afib
Stage 2 - Pre-Afib
Stage 3 - Atrial fibrillation
A - Paroxysmal
B - Persistent
C - Longstanding Persistent
D - Successful Afib Ablation
Stage 4 - Permanent Afib
Mechanism of Atrial fibrillation
atrial cardiomyopathy cause by atrial remodeling from both electrophysiologic and anatomic changes
component of CHA2DS2-VA
C - CHF
H- Hypertension
A2 - age of ≥75
D - DM
S2 - stroke prior
V - Vascular disease
A- Age 65-74
2 or more -> oral anticoagulation is recommended
1 -> oral anticoagulation should be consider
factors that increases the risk for Stroke that is not included in CHA2DS2-VASc
consider oral anticoagulation
Question?
continue based on stroke risk score
in patient with Afib, Cardiac conditions that needs to give oral anticoagulation regardless of CHA2DS2-VASc score.
-moderate to severe MS
- mechanical valve
- HCM
- Cardiac amyloidosis
Anticoagulation and Typical Atrial flutter
should you continue anticoagulation after successful ablation?
YES, if they have previously detected AFib
Mechanism of action of DOAC
“xaban” inhibits Xa
Dabigatran inhibits Thrombin
Clinical trials associated with DOAC
RE-LY - Dabigatran
ROCKET-AF - Rivaroxaban
ARISTOTLE - Apixaban
ENGAGE AF - Edoxaban
renally excreted DOAC
Dabigatran - 80%
Rivaroxaban - 2/3
Edoxaban -35%
APIXABAN - 25% only
Criteria for dose adjustment for Apixaban?
2 of 3
- Age ≥80
- Weight ≤60
Crea ≥1.5 or 137
Criteria for dose adjustment for Edoxaban?
if weight is ≤60kg, or
concomitant use of P-glycoprotein inhibitor
Level of recommendation for using apixaban for eGFR <15 or dialysis
Class IIb
reversal agent for DOAC
see pic
AF complication ACS or PCI
how long do you need to put the patient on triple anti therapy after PCI
1-4 weeks then continue OAC+P2Y12 inhibitor
Duration of anticoagulation after cardioversion
≥4 weeks
***after 4 weeks, you recheck the stroke risk if anticoagulation is still indicated.